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In 2016, disseminated tuberculosis caused by Mycobacte-
rium caprae was diagnosed in a captive Borneo elephant 
in Japan. The bacterium was initially identified from clini-
cal isolates. An isolate collected during a relapse showed 
isoniazid monoresistance and a codon 315 katG mutation. 
Elephants are susceptible to infection by some members of the Mycobacterium tuberculosis complex (MTBC) 
(1). The MTBC comprises several genetically homo-
geneous species that have a wide range of hosts and can 
cause tuberculosis in humans and in animals. Infection in 
elephants is presumed to originate from human caretakers 
who have tuberculosis; however, transmission between el-
ephants or from other animals is also possible (2–4).
Phylogenetic events during the divergence of MTBC 
species are represented within the genomes of MTBC spe-
cies (5). Whole-genome sequencing has shown that single-
nucleotide polymorphism (SNP) microevolution occurs in 
MTBC strains in the host.
We describe mycobacterial infection in an elephant 
that was caused by a relatively uncommon species of 
MTBC. M. caprae infection, a species of the MTBC, was 
diagnosed in a captive Borneo elephant (Elephas maximus 
borneensis) that was brought directly from Borneo island 
after being orphaned.
The Study
In February 2016, an ≈17-year-old female Borneo elephant 
in the Fukuyama Zoo (Fukuyama, Japan) had low-grade fe-
ver (99.9°F), anorexia, progressive weight loss, and cough 
with sputum. The elephant had been housed alone in a 
facility with a roofed room and an open-air enclosure and 
had no contact with other animals. She was seropositive by 
Chembio DPP VetTB Assay for Elephants (Chembio Di-
agnostic Systems, Inc., Medford, NY, USA), which detects 
antibodies to CFP10/ESAT-6 and MPB83 antigens (6,7). 
Submitted specimens to the National Hospital Orga-
nization Kinki-chuo Chest Medical Center (Sakai, Japan) 
were sputum, feces, urine, and vaginal discharge recov-
ered from the floor. Acid-fast bacilli were visualized on 
Ziehl-Neelsen staining performed according to standard 
methods (8). Isolates with smooth to greasy, domed, non-
chromogenic colonies were recovered from all submitted 
samples using both 7H11 agar and MGIT broth (Becton 
Dickinson, Fukushima, Japan) and identified as MTBC 
using loop-mediated isothermal amplification (Eiken 
Chemical, Tokyo, Japan) and TaqMan PCR (Roche Diag-
nostics, Tokyo, Japan) (9). 
A single colony was sequenced using MiSeq (Illu-
mina, Inc., Tokyo, Japan). Raw reads were trimmed by 
base quality and were mapped to the M. tuberculosis refer-
ence genome, H37Rv (GenBank accession no. CP003248). 
The initial isolate, EPDC01, was characterized by the 
presence and absence of genomic regions of difference, 
the mutation (G to A) of oxyR285, and M. caprae–specific 
SNPs in lepA (10) (Table 1, https://wwwnc.cdc.gov/EID/
article/24/10/18-0018-T1.htm). These results unexpectedly 
suggested that the causative agent of tuberculosis in this 
elephant was M. caprae. The regions of difference analy-
sis suggested that EPDC01 belonged to the Allgäu type of 
M. caprae found in red deer (Cervus elaphus) (11). How-
ever, when we used kSNP3 (12), a kmer-based method, 
to compare SNPs from the entire genome of EPDC01 
to previously published Allgäu and Lechtal types of M. 
caprae and other MTBC species, the results showed this 
isolate was not closely related to either Allgäu or Lech-
tal types (Figure; online Technical Appendix Figure, 
https://wwwnc.cdc.gov/EID/article/24/10/18-0018-
Techapp1.pdf) (13).
The isolate was susceptible to isoniazid, rifampin, eth-
ambutol, and levofloxacin according to the broth microdilu-
tion method (BrothMIC MTB-1; Kyokuto Pharmaceutical, 
Inc, Tokyo, Japan). It also was susceptible to pyrazinamide 
using Bactec MGIT 960 PZA kit (Becton Dickinson).
The infected elephant initially weighed 2,400 kg; 
isoniazid (4.5–7 mg/kg), pyrazinamide (31–33 mg/kg), 
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and levofloxacin (11 mg/kg) were administered rectally, 
once a day. When weighing on a scale was not possible, 
the elephant’s weight was estimated using the chest girth 
method. After 1 month of treatment, the vaginal discharge 
disappeared, and the elephant’s sputum culture became 
negative after 2 months. After 6 months, the multidrug 
treatment was interrupted for 3 weeks because of severe 
gastrointestinal disturbance and hepatic dysfunction. 
Rectal administration of isoniazid and pyrazinamide was 
resumed for an additional 3 months after recovery from 
adverse effects. Follow-up trunk wash samples were cul-
ture negative, but M. caprae was isolated from a sputum 
sample collected from the chin in February 2017. This 
new isolate was resistant to isoniazid. The drug regimen 
was then changed to oral rifampin (10 mg/kg) and rectal 
ethambutol (30 mg/kg), levofloxacin (10 mg/kg), and pyr-
azinamide (30 mg/kg). Under the modified treatment, the 
recurrence symptoms disappeared, and the routine sputum 
cultures became negative.
We also sequenced the recurrent isoniazid-resistant 
isolate (EPDC02) using a MiSeq and detected a mutation 
in katG where Ser-315 was replaced by 113 Thr (S315T). 
No mutations were detected in other representative drug re-
sistance–related genes, such as rpoB (rifampin); rrn, gidB, 
and rpsL (streptomycin); embABC (ethambutol); pncAC 
(pyrazinamide); and gyrAB (quinolone). The pairwise dis-
tance between the initial and relapse isolates (EPDC01 and 
EPDC02) involved at least 7 single-nucleotide variants 
found in coding regions (Table 2).
For serologic monitoring of treatment, we tested ar-
chived serum samples collected before and during treat-
ment using the DPP assay. Although a sample in November 
2003 was reactive on CFP10/ESAT-6 but not on MPB83, at 
the time of culture-based tuberculosis diagnosis (February 
2016), the reaction to CFP10/ESAT-6 was more intense, 
and the complete band of MPB83 appeared. The intensity 
to 2 test lines gradually decreased during the initial treat-
ment (September 2016) and disease recrudescence (Febru-
ary 2017). The modified 18-month course of treatment is 
scheduled to end in October 2018.
Employees at the zoo were assessed for tuberculo-
sis based on symptoms, radiographs, and serology us-
ing the QuantiFERON-TB Gold test (QIAGEN, Tokyo, 
Japan); none had active tuberculosis. Clinical examina-
tion, culture, PCR, and tuberculin skin test were used 
to evaluate as many primates and hoofstock as possible 
in the collection, and no tuberculosis-positive animals 
were identified.
Conclusions
A better understanding of tuberculosis in elephants is 
crucial to improve medical management and reduce risk 
of transmission to other animals and humans. During the 
initial treatment of the elephant reported here, treatment 
was interrupted for 3 weeks because of adverse effects. 
Reducing the dose of isoniazid was the probable cause of 
the acquired isoniazid resistance. When treating tuberculo-
sis in elephants, the benefits and adverse effects should be 
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Figure. Phylogenetic tree 
of isolate EPDC01 from a 
captive Borneo elephant 
with Mycobacterium caprae 
infection, Japan, 2016, and 8 
Mycobacterium caprae strains 
(Allgäu and Lechtal types) 
from a report by Broeckl et al. 
(13). Short reads of M. caprae 
strains were assembled by 







before analysis. Core single-
nucleotide polymorphisms of all 
13 strains, including reference 
M. tuberculosis complex strains 
(M. bovis, AF2122/97 [GenBank 
accession no. NC_002945.4]: M. orygis, 112400015 [NZ_APKD00000000.1]: M. pinnipedii, BAA-688 [MWXB00000000.1]: M. 
microti, strain 12 [CP010333.1]: and M. mungi, BM22813 [NZ_LXTB00000000.1]), were determined and used for tree construction 
based on neighbor-joining by kSNP3 (12). A tree including all 61 strains described by Broeckl et al. (13) is shown in the online 
Technical Appendix Figure (https://wwwnc.cdc.gov/EID/article/24/10/18-0018-Techapp1.pdf). Scale bar indicates nucleotide 
substitutions per site.
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weighed carefully. The DPP provides an indirect measure 
of infection and disease status (6). In this elephant, declin-
ing DPP reactivity was thought to indicate a response to 
therapy; however, more sensitive biomarkers to monitor 
therapeutic response are needed.
Previously, epidemiologic observations of elephant 
tuberculosis by IS6110 restriction fragment-length poly-
morphism have been based on evidence of local zoo-
notic risk for transmission to humans or of an epizootic 
reservoir for transmission to elephants or other animal 
species (goats and rhinoceros) (1,14). Recently, M. tu-
berculosis strains in 2 captive elephants in a small trav-
eling circus harbored 3 nucleotide changes, according to 
whole-genome sequencing (15). M. tuberculosis has 
been isolated from Asian elephants among regions in 
southern Asia (3,4). Although the transmission routes 
have not been defined, our result and those of previous 
reports indicate that MTBC species may be spilling over 
into elephants.
Our finding emphasizes the need to identify the 
species of MTBC when tuberculosis is diagnosed 
in elephants. Although corroborating epidemiologic 
evidence of transmission has not been discovered, 
genomic data of the M. caprae isolates has been regis-
tered in the open database (BioProject ID PRJDB6469; 
BioSample ID SAMD00098240 for EPDC01, 
SAMD00098241 for EPDC02). Accumulation of ge-
nomic data of clinical isolates is expected to be helpful 
for future comparative studies.
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